Met, metastasis, motility and more

被引：2206

作者：

Birchmeier, C

Birchmeier, W

Gherardi, E

Vande Woude, GF

机构：

[1] Van Andel Res Inst, Grand Rapids, MI 49503 USA

[2] Max Delbruck Ctr Mol Med, Dept Neurosci, D-13122 Berlin, Germany

[3] Max Delbruck Ctr Mol Med, Dept Canc Res, D-13122 Berlin, Germany

[4] MRC Ctr, Cambridge CB2 2QH, England

来源：

NATURE REVIEWS MOLECULAR CELL BIOLOGY | 2003年 / 4卷 / 12期

关键词：

D O I：

10.1038/nrm1261

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Hepatocyte growth factor/scatter factor and its receptor, the tyrosine kinase Met, arose late in evolution and are unique to vertebrates. In spite of this, Met uses molecules such as Gab1 - homologues of which are present in Caenorhabditis elegans and Drosophila melanogaster for downstream signalling. Pivotal roles for Met in development and cancer have been established: Met controls cell migration and growth in embryogenesis; it also controls growth, invasion and metastasis in cancer cells; and activating Met mutations predispose to human cancer.

引用

页码：915 / 925

页数：11

共 109 条

[81] Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses
Schaeper, U
Gehring, NH
Fuchs, KP
Sachs, M
Kempkes, B
Birchmeier, W
[J]. JOURNAL OF CELL BIOLOGY, 2000, 149 (07) : 1419 - 1432
[82] Hepatocyte growth factor scatter factor (HGF/SF) signals via the STAT3/APRF transcription factor in human hepatoma cells and hepatocytes
Schaper, F
Siewert, E
GomezLechon, MJ
Gatsios, P
Sachs, M
Birchmeier, W
Heinrich, PC
Castell, J
[J]. FEBS LETTERS, 1997, 405 (01) : 99 - 103
[83] SCATTER FACTOR/HEPATOCYTE GROWTH-FACTOR IS ESSENTIAL FOR LIVER DEVELOPMENT
SCHMIDT, C
BLADT, F
GOEDECKE, S
BRINKMANN, V
ZSCHIESCHE, W
SHARPE, M
GHERARDI, E
BIRCHMEIER, C
[J]. NATURE, 1995, 373 (6516) : 699 - 702
[84] Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
Schmidt, L
Duh, FM
Chen, F
Kishida, T
Glenn, G
Choyke, P
Scherer, SW
Zhuang, ZP
Lubensky, I
Dean, M
Allikmets, R
Chidambaram, A
Bergerheim, UR
Feltis, JT
Casadevall, C
Zamarron, A
Bernues, M
Richard, S
Lips, CJM
Walther, MM
Tsui, LC
Geil, L
Orcutt, ML
Stackhouse, T
Lipan, J
Slife, L
Brauch, H
Decker, J
Niehans, G
Hughson, MD
Moch, H
Storkel, S
Lerman, MI
Linehan, WM
Zbar, B
[J]. NATURE GENETICS, 1997, 16 (01) : 68 - 73
[85] CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity
Schmits, R
Filmus, J
Gerwin, N
Senaldi, G
Kiefer, F
Kundig, T
Wakeham, A
Shahinian, A
Catzavelos, C
Rak, J
Furlonger, C
Zakarian, A
Simard, JJL
Ohashi, PS
Paige, CJ
GutierrezRamos, JC
Mak, TW
[J]. BLOOD, 1997, 90 (06) : 2217 - 2233
[86] The Caenorhabditis elegans EGL-15 signaling pathway implicates a DOS-like multisubstrate adaptor protein in fibroblast growth factor signal transduction
Schutzman, JL
Borland, CZ
Newman, JC
Robinson, MK
Kokel, M
Stern, MJ
[J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (23) : 8104 - 8116
[87] Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2
Schwall, RH
Chang, LY
Godowski, PJ
Kahn, DW
Hillan, KJ
Bauer, KD
Zioncheck, TF
[J]. JOURNAL OF CELL BIOLOGY, 1996, 133 (03) : 709 - 718
[88] Shaharabany M, 2001, CANCER RES, V61, P4873
[89] Smart drugs: Tyrosine kinase inhibitors in cancer therapy
Shawver, LK
Slamon, D
Ullrich, A
[J]. CANCER CELL, 2002, 1 (02) : 117 - 123
[90] Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
Slamon, DJ
Leyland-Jones, B
Shak, S
Fuchs, H
Paton, V
Bajamonde, A
Fleming, T
Eiermann, W
Wolter, J
Pegram, M
Baselga, J
Norton, L
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) : 783 - 792

← 2 3 4 5 6 7 8 9 10 11 →